INTRODUCTION
The envelope or surface material of hepatitis type B virus (HBV) is referred to as hepatitis B surface antigen (HBsAg). This virus product is made in overwhelming excess by infected hepatocytes (Almeida, ~972; Robinson, I977) . Purified 22 nm particles associated with HBsAg have considerable biophysical and biochemical heterogeneity (Dreesman et al. I972b ) and contain at least seven to nine distinct polypeptides when analysed by dissociating sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis (PAGE) (Gerlich & May, I973; Gerin, t974; Chairez et al. ~975; Cabral et al. I978) . In addition, several laboratories have identified normal serum protein antigens in intimate association with purified 22 nm particles (Millman et al. 197I ; Dreesman et al. 1972a; Neurath et al. 1974; Burrell, ~975; Stannard & Moodie, 1976; Cabral et al. I978 ; Vnek et aL ~978)-More recently, our laboratory as well as Gerin's noted that albumin antigenic activity is related to a polypeptide of tool. wt. 68ooo (P68) derived from solubilized HBsAg (Dreesman & Gerin, I978) . In the present study, we have analysed the immunochemical characteristics of four major HBsAg polypeptides and have examined their cross-reactivity with human serum albumin (HuSA).
METHODS
Purification of HBsdg. Spherical particles (mean diam. 22 nm) containing HBsAg, subtype adw, were isolated from human plasma as previously described (Dreesman et al. I972a; Hollinger, I974) . Briefly, the particles were pelleted by high-speed centrifugation, oo2z-~317/8o/oooo-399I $02.00© 198o SGM treated at pH 2. 4 at room temperature for I h and banded twice on isopycnic CsC1 gradients, followed by a rate zonal centrifugation in a pre-formed linear CsC1 gradient.
Isolation of HBsAg polypeptides. The polypeptides were obtained by preparative SDS-PAGE as previously described (Cabral et al. I978) . Briefly, purified HBsAg particles were solubilized by heating at Ioo °C for 2 min in o'5 M-urea, 1% SDS and 1% 2-mercaptoethanol (2-ME) and were then placed on a Io% polyacrylamide gel prepared in I4'5 x I25 mm cylindrical tubes. Electrophoresis was run at 2o mA/gel tube. A thin longitudinally cut section of gel was stained with o'25% Coomassie brilliant blue. The corresponding segments for each polypeptide were cut out of the intact gel and the purified proteins were recovered from the gel slice. The proteins were concentrated by lyophilization and their purity was checked by slab-gel electrophoresis (Chairez et al. I974) .
Iodination. Purified HuSA and polypeptides derived from HBsAg were iodinated by a modification of the method described by Greenwood et al. (1963) . The following reagents were successively added to 5oot~Ci of Na-125I (New England Nuclear Corp., Boston, Mass., U.S.A.): Io/~1 of o.oi M-phosphate-buffered saline (PBS), pH 7"2; 5/tg of polypeptide protein in Io#1; and 25/Ag of chloramine-T (Eastman Kodak Chemical Co., Wilmington, Del., U.S.A.) in Io td. The reaction was stopped after 3o s by the addition of 50/~g of sodium metabisulphite (Fisher Chemical Co., Fair Lawn, N.J., U.S.A.) in IO/I.1 and Ioo/zg of potassium iodide (Sigma Chemical Co., St. Louis, Mo., U.S.A.) in Io/d. The sample was dialysed extensively against PBS, pH 7"2. Over 9o o~/o of the radioactivity was precipitated with 2o °i, trichloroacetic acid (TCA). The specific activities of all the labelled preparations of P22 and of HuSA used in these studies ranged from 8 to I6/~Ci/#g. The protocol used to iodinate HBsAg was done as previously described (Hollinger et al. I975) . The specific activities of labelled HBsAg preparations ranged from 3 to 5/~Ci//~g.
The antigenic activity of labelled P22, P68 and of labelled HuSA was examined as folIows: a homologous guinea-pig serum was titrated against each respective labelled antigen. At the same time, the antiserum was also reacted with a ~ : ~o dilution of the above labelled antigen to which unlabelled protein had been added to adjust the protein quality equivalent to that of the first experiment. Plots generated from the resultant RIA titration data were superimposable, showing that no antigenic alteration had occurred during iodination.
Each iodinated preparation was again analysed by SDS-PAGE and by chromatography on Sephadex G-I5o. The results indicated that each iodinated preparation fractionated with mol. wt. values similar to that demonstrated before labelling. More importantly, a mixture of 13q-HuSA and 225I-P68 eluted from a I X 30 cm column of Sephadex G-i5o suspended in PBS as a single peak with the superimposed pattern of the two labels. No material of mol. wt. greater than that of HuSA and P68 was observed. This provides additional data that no damage had occurred during the iodination procedure and that no aggregation had taken place.
Antisera. Four adult (4oo to 5oo g) male Hartley guinea-pigs were inoculated with each designated antigen in the rear and front footpads and in the hind flanks on days o, I4, and 28, respectively. Animals were also injected with purified HBsAg, HuSA, denatured HuSA and HBsAg polypeptides with mol. wt. of 22 ooo (P22), 25 ooo (P25), 52 ooo (P52) and 68 ooo (P68). Each inoculum consisted of 25//g of antigen emulsified with an equal volume of complete Freund's adjuvant. Guinea-pigs were evaluated for the development of humoral immunity IO days after the second booster.
Radioimmunoprecipitation-titration assay. A double-antibody radioimmunoprecipitation assay (RIA-DA) was performed by a modification of procedures described previously by this laboratory (Hollinger et al. I97I; Spira et al. I974) .. Guinea-pig antisera prepared against HBsAg, HuSA, P22, P25, P52 and P68 were used as the primary antibodies. The dilutions were made in TO°~, normal guinea-pig serum (NGPS) in PBS, pH 7.2. To TOO/tl of a fivefold dilution of primary antibody was added TOO/d of the labelled antigen diluted in I o~, NGPS in PBS, pH 7.2, to contain 6oooo ct/min in loo/d. The mixture was incubated overnight at 4 °C. Rabbit anti-guinea-pig IgG (R~GP-IgG) was used as the second antibody, diluted to an optimal concentration predetermined by quantitative precipitation against lo°~ NGPS. After the addition of R~GP-IgG, the incubation was continued for 2 h at 37 °C. The test tubes were then centrifuged at aooo rev/min for 30 rain and the precipitated radioactivity was counted in an automatic gamma counter (Nuclear Chicago, Des Plaines, Ill., U.S.A.). The following controls were simultaneously done with each assay. The negative control consisted of o/ lo ,~ NGPS in PBS to replace the primary antibody. The TCA-precipitable counts control was performed by replacing the second antibody with 2o0/~1 of 2o% TCS.
The percentage of radioactive antigen precipitated by the specific antibody was determined from a formula used previously by Chisari et al. The reaction mixture (antigen plus antibody) was incubated overnight at 4 °C. Then a constant amount of labelled antigen diluted in T o~ NGPS in PBS, pH 7.2, to obtain 6oooo ct/min/Ioo/¢1, was added to each tube. After an incubation period of 2 h at 37 °C, R~GP-IgG was added. The remainder of the procedure was carried out as described above for the direct titration RIA-DA technique.
Isoelectricfocusing in sucrose. Ten mg of commercial HuSA (Sigma Chemical Co.) was purified by electrophoresis using a sucrose ampholite gradient with a pH range of 3 to ~o, in an LKB electrofocusing apparatus, at 4 °C and 8oo V for 72 h as described by Carlsson & Perlmann (T969) . The HuSA was dialysed against I °,o glycine before electrofocusing. A major fraction with pI values ranging from 5'T to 5"3 was pooled and utilized as purified HuSA for the remainder of the study. Only one band with an estimated tool. wt. of 68ooo was seen when the purified preparation of HuSA was analysed by SDS-PAGE. In addition, a single precipitin band with the electrophoretic mobility of albumin was noted when the material was analysed by immunoelectrophoresis using a horse anti-whole normal human serum antibody reagent. To serve as an additional control, purified HuSA was fractionated on preparative SDS-PAGE gels as described above for the preparation of HBsAg polypeptides. The recovered denatured HuSA preparation was used to immunize guinea-pigs.
Absorption of antisera. Samples of guinea-pig anti-polypeptide sera and of anti-HuSA sera were absorbed with commercial HuSA rendered insoluble by cross-linking with glutaraldehyde by the method described by Avrameas & Ternynck (J969) . The actual absorption procedure was performed as previously described (Dreesman et al. 1972a ). 
RESULTS

HBsA g polypeptides
Nine polypeptides are routinely resolved when purified preparations of HBsAg/adw are O, / solubilized and analysed by SDS-PAGE in Io/o gels. The tool. wt. of each polypeptide was estimated by comparing its relative mobility with that of known tool. wt. markers in a Io % acrylamide gel (Fig. I) . The calculated tool. wt. were as follows : 22 ooo, 25 ooo, 3 ~ ooo, 35ooo, 4oooo, 45ooo, 52ooo, 68ooo and 97ooo. It should be pointed out that the relative amount of each subunit is highly reproducible; over the course of several years, 65 preparations of purified HBsAg, isolated from individual plasma donors, of both adw and ayw subtypes yielded similar patterns. In addition to the nine polypeptides listed above, it was noted that two polypeptides, with tool. wt. of 27o0o and 720o0, were observed in approximately half of the purified antigen preparations.
The major polypeptides associated with purified HBsAg 22 nm particles, as quantified by Coomassie brilliant blue staining, were the subunits with tool. wt. of 22000 (P22), 25 ooo (P25), 52 ooo (P52) and 68 ooo (P68). Each of these four subunits was fractionated by preparative PAGE as described in Methods. The purity and tool. wt. of each preparation was confirmed by a subsequent analytical PAGE analysis (Fig. 2) . Retention of antigenic activity of the purified P22 and P68 preparations was demonstrated in that anti-HBs precipitated 65 % and 9o %, respectively, of iodinated preparations of each (Fig. 3b, c) .
Antisera titrations
Antisera were prepared to purified HBsAg, to HuSA and to the following polypeptides derived from HBsAg-associated particles -P22, P25, P52 and P68. At least four animals were inoculated with each. Each serum was tested for antibody activity utilizing labelled Fig. 2 . Polypeptides of solubilized preparation of HBsAg as separated by SDS-PAGE in lo % gels (bottom panel). Four major polypeptides were isolated as described in Methods and their purity was evaluated by SDS-PAGE (top four panels). Separated polypeptides were detected by staining in Coomassie brilliant blue and destaining in 7 % acetic acid. 277 preparations of HBsAg, HuSA, P22 and P68 by RIA-DA. Representative titration data are illustrated in Fig. 3 -Titration of each antiserum with HBsAg showed that the antigenic determinant associated with each polypeptide is accessible on the surface of the intact HBsAg/adw particle (Fig. 3 a) . In addition, antisera produced to purified HuSA also reacted with labelled HBsAg, re-affirming that HuSA antigenic determinants are present in a purified preparation of HBsAg. It was of interest that purified labelled P68 reacted with anti-HBsAg and with anti-P68 in much the same way as did intact labelled HBsAg (Fig.  3a, c) . In contrast, all sera except anti-HuSA reacted with labelled Pz/ (Fig. 3b) . In confirmation of this observation was the fact that antisera specific for HBsAg, P68 and HuSA reacted with labelled HuSA, but that antisera to the other three polypeptides failed to react Antisera were used at a dilution at which they would precipitate 50 % of the labelled antigen used in each experiment. The unlabelled competing proteins were: O, HBsAg; O, P22: ~k, P68; ~, HuSA. with HuSA (Fig. 3 d) . Identical curves were observed when the titration was carried out with guinea-pig antisera prepared by injection of SOS-denatured HuSA (data not shown). This suggested that a purified preparation of P68 contained a mixture of HBV-specified molecules and HuSA which had similar tool. wt.
Specificity of antigen-antibody reaction
The specificity of this reaction was next tested by competition RIA and the results are illustrated in Fig. 4 . These are representative experiments performed using a minimum of three antisera per antigen.
Several points can be drawn from this series of experiments: (i) preparations of P22 contain no antigenic reactivity when tested with the competition reaction utilizing antiHuSA sera (Fig. 4a, b) ; (ii) the cross-reactivity of HBsAg, HuSA and P68 is illustrated in the entire series of experiments shown in Fig. 4 ; (iii) the presence of P22 antigenic determinants in P68 preparations is noted in that P22 competes with the homologous P68/anti-P68 reaction by 3o to 4o °/o, depending on the anti-P68 serum used (Fig. 4c) . These observa-tions confirmed the results illustrated in Fig. 3 . It was unexpected to find that P22 competed on essentially the same level when added to a reaction mixture of anti-P68 and labelled HuSA (Fig. 4d) .
The results of the competition-inhibition assays are summarized in Table I . The most significant observation presented in this table is that P22 can inhibit the reactions between anti-P68 and P68 and between anti-P68 and HuSA to the same level, approx. 30 to 35 o/.
A possible explanation for the above results was that animals immunized with P68 produced multispecific antibodies which could combine with either HBV-specified antigenic determinants (V) or with HuSA antigenic determinants (A). To test this hypothesis, antiHuSA and anti-P68 sera were absorbed with insolubilized HuSA. Control sera were treated in the same fashion with the exception that PBS was used instead of insolubilized HuSA. The control and the absorbed sera were each titrated for antibody activity for labelled P22, P68 and HuSA (Fig. 5) . The results indicate that anti-P68 sera contained two distinct populations with specificity for V and A antigenic determinants. Absorption of anti-P68 with HuSA (i) failed to significantly affect its reactivity for P22, (ii) decreased reactivity for P68 and (iii) completely abolished reactivity for HuSA (Fig. 5a to c) . In confirmation of this was the fact that absorbed anti-HuSA no longer reacted with labelled HuSA (Fig. 5) .
DISCUSSION
The association of HuSA antigenic activity with purified preparations of HBsAg has been noted by a number of investigators (Millman et I978) . However, the following critical questions dealing with this association have not been investigated. (i) Are human serum components present as contaminants on the surface of HBsAg or are these proteins, such as HuSA, integral components of the intact HBsAg particle? (ii) What is the nature of the serum proteins which are derived from HBsAg? Are they present as native serum proteins or are they modified during the biosynthesis of HBsAg in the infected hepatocyte?
In the present study we have established that a major HBsAg polypeptide with a tool. wt. of 68ooo, termed P68, reacted with antibody produced in guinea-pigs immunized with purified HuSA. In addition, antisera prepared against purified P68 reacted with purified HuSA. It was also noted that antisera prepared to three smaller HBsAg-derived polypeptides -P22, P25 and P52 -reacted with P68 but not with purified HuSA. Concomitantly, anti-HuSA failed to react with purified labeIled P22.
Several hypotheses can be developed to explain the above observations. The most obvious explanation is that two molecules, with the same tool. wt., are present in the purified preparations of P68. One molecule would be represented as intact HuSA and the second would be a virus polypeptide with HBsAg determinants. The most meaningful data relevant to this hypothesis were derived from the competition experiments summarized in Table 1 . If two distinct molecules were present, animals immunized with the purified P68 should produce a population of antibodies reacting with A sites and yet another population reacting with V sites. In that case, one would expect the competition reaction performed with the homologous P68 antigen-antibody system in conjunction with unlabelled HuSA and that with unlabelled P22 to add up to a total of loo ~.~. However, this total was in excess of Ioo% in the presence of 16o/~g of competing proteins in each of five independent experiments (Table I) . Of particular interest, however, is the fact that P22 can inhibit the reaction between lz~I-HuSA and anti-P68 to approximately the same level (3o to 35 %) as it inhibits the homologous P68 reaction. Therefore, antibodies present in the anti-P68 serum could be blocked from reacting with HuSA by the addition of P22. [t should be noted that P68 and P22 blocked 78 ~o and 65 o+,, respectively, of the reaction between anti-HBs and 1-~q-HBsAg. This indicated (i) that the antibodies present in the anti-P68 serum were multispecific (Richards et al. I975; Secher, I977) and combined with either A or V antigenic determinants or (ii) that both A and V determinants were present on one molecule of some of the molecules present in these preparations. The absorption experiments illustrated in Fig. 5 tend to rule out the presence of multispecific antibodies. Anti-P68 serum absorbed with insolubilized albumin (i) resulted in antibody activity which was unaltered in reactivity with P22, (ii) decreased by 2o° o its reactivity with P68 and (iii) completely abolished its reactivity with HuSA.
Recently, two independent laboratories have reported that purified HBsAg derived from HBeAg-positive sera contains a receptor which combines with polymerized human or chimpanzee albumin (Imai et al. 1979; Neurath & Strick, I979) . Data from our laboratory have shown that this receptor is associated with the purified P22 and P68 receptors (unpublished data). Therefore, a small sequence of virus-specific amino acid could adsorb to HuSA intracellularly. However, it is likely that the small HBsAg-specific peptide would be dissociated during the SDS-PAGE purification of the P68 molecule.
The third possibility, which best fits the data presented in this study, would require that a modified molecule is synthesized in an infected hepatocyte so that a limited sequence of HBsAg-specific amino acids bearing the V antigenic determinant is inserted into the HuSA molecule. This is an attractive hypothesis in that an infectious agent with a limited amount of genetic material could utilize a structural building block by merely inserting a limited sequence of amino acid into a protein already synthesized by the host cell. This could take place at the level of either transcription or translation. W. S. Robinson (personal communication) has recently shown that an HBsAg-producing hepatoma cell line established by Alexander et al. 0978 ) contains 2 to 5 copies of HBV DNA per cell and that this virus DNA is integrated into the host cell chromosomes. If it is assumed that HBV DNA is also integrated in the productively infected cells, an mRNA could be transcribed which could code for a hybrid HuSA molecule containing a limited number of amino acids which would confer HBsAg specificity to the molecule. It should be pointed out that the P68 polypeptide has not been demonstrated in purified HBsAg derived from the HBsAg-producing hepatoma cell line (J. L. Gerin, personal communication). Alternatively, a hybrid HuSA containing HBsAg sequences could also result from a unique translation step in productively infected cells. However, to our knowledge, no similar observations have been published to verify the latter hypothesis.
During the final preparation of this manuscript, Skelly et al. (1979) reported the characteristics of a P68 component (termed P64 in their study) which they isolated from purified HBsAg by fractionation on concanavalin A-Sepharose 4B columns after disruption of the 22 nm particles with 2 % Triton X-Ioo. Similar to our observations, these authors reported that P68 contained albumin antigenic activity and that it was an integral constituent of the HBsAg particle. In reviewing the data, it was observed that the fraction which contained P64 reacted with anti-HBs, in confirmation of our observations. Monjardino & Crawford (I979) have proposed that the 22ooo tool. wt. peptide is the only polypeptide constituent of HBsAg. The data presented in these recent studies provide interesting models for investigation in greater detail in attempts to elucidate the biochemical complexity of HBsAg. Work is being conducted in our laboratory to establish the tryptic peptide maps of the various subunits of protein implicated in this study.
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